Epidemiologic and Clinical Characteristics of Novel Coronavirus Infections Involving 13 Patients Outside Wuhan, China

De Chang,Minggui Lin,Lai Wei,Lixin Xie,Guangfa Zhu,Charles S. Dela Cruz,Lokesh Sharma
DOI: https://doi.org/10.1001/jama.2020.1623
IF: 11.816
2020-03-17
JAMA
Abstract:In December 2019, cases of pneumonia appeared in Wuhan, China. The etiology of these infections was a novel coronavirus (2019-nCoV),<sup><a class="ref-link section-jump-link" href="#jld200007r1">1</a></sup><sup>,<a class="ref-link section-jump-link" href="#jld200007r2">2</a></sup> possibly connected to zoonotic or environmental exposure from the seafood market in Wuhan. Human-to-human transmission has accounted for most of the infections, including among health care workers.<sup><a class="ref-link section-jump-link" href="#jld200007r3">3</a></sup><sup>,<a class="ref-link section-jump-link" href="#jld200007r4">4</a></sup> The virus has spread to different parts of China and at least 26 other countries.<sup><a class="ref-link section-jump-link" href="#jld200007r1">1</a></sup> A high number of men have been infected, and the reported mortality rate has been approximately 2%, which is lower than that reported from other coronavirus epidemics including severe acute respiratory syndrome (SARS; mortality rate, &gt;40% in patients aged &gt;60 years)<sup><a class="ref-link section-jump-link" href="#jld200007r5">5</a></sup> and Middle East respiratory syndrome (MERS; mortality rate, 30%).<sup><a class="ref-link section-jump-link" href="#jld200007r6">6</a></sup> However, little is known about the clinical manifestations of 2019-nCoV in healthy populations or cases outside Wuhan. We report early clinical features of 13 patients with confirmed 2019-nCoV infection admitted to hospitals in Beijing.
What problem does this paper attempt to address?